S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Blonder Tongue Laboratories Stock Forecast, Price & News

-0.03 (-2.80%)
(As of 11/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
49,206 shs
Average Volume
828,837 shs
Market Capitalization
$12.89 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive BDR News and Ratings via Email

Sign-up to receive the latest news and ratings for Blonder Tongue Laboratories and its competitors with MarketBeat's FREE daily newsletter.

About Blonder Tongue Laboratories

Blonder Tongue Laboratories, Inc. operates as a technology development and manufacturing company, which engages in delivering television signal encoding, transcoding, digital transport, and broadband product solutions for applications. It also offers system operators and integrators serving the cable, broadcast, satellite, institutional, and professional video markets with solutions for the provision of content contribution, distribution, and video delivery to homes and businesses. The company was founded by Ben H. Tongue and Isaac S. Blonder in 1950 and is headquartered in Old Bridge, NJ.


See More Headlines

Industry, Sector and Symbol

Stock Exchange
Radio & t.v. communications equipment
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$16.38 million
Book Value
$0.30 per share


Net Income
$-7.47 million
Pretax Margin




Free Float
Market Cap
$12.89 million
Not Optionable

Company Calendar

Last Earnings
Fiscal Year End


Overall MarketRank

1.41 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.0 5 -4 -3 -2 -1 -

Blonder Tongue Laboratories (NYSEAMERICAN:BDR) Frequently Asked Questions

Are investors shorting Blonder Tongue Laboratories?

Blonder Tongue Laboratories saw a increase in short interest in the month of October. As of October 29th, there was short interest totaling 87,600 shares, an increase of 20.0% from the October 14th total of 73,000 shares. Based on an average daily volume of 338,100 shares, the days-to-cover ratio is presently 0.3 days. Currently, 1.3% of the company's stock are short sold.
View Blonder Tongue Laboratories' Short Interest

How were Blonder Tongue Laboratories' earnings last quarter?

Blonder Tongue Laboratories, Inc. (NYSEAMERICAN:BDR) issued its quarterly earnings results on Friday, May, 15th. The technology company reported ($0.21) EPS for the quarter. The technology company had revenue of $4.05 million for the quarter. Blonder Tongue Laboratories had a negative trailing twelve-month return on equity of 56.15% and a negative net margin of 8.71%.
View Blonder Tongue Laboratories' earnings history

Who are Blonder Tongue Laboratories' key executives?

Blonder Tongue Laboratories' management team includes the following people:
  • Edward R. Grauch, President & Chief Executive Officer
  • Allen Horvath, Senior Vice President-Operations
  • Eric S. Skolnik, CFO, Secretary, Treasurer & Senior Vice President
  • Ronald V. Alterio, Chief Technology Officer & Senior VP-Engineering
  • Robert J. Pallé, Director & Managing Director-Strategic Accounts

What other stocks do shareholders of Blonder Tongue Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Blonder Tongue Laboratories investors own include VBI Vaccines (VBIV), Vaxart (VXRT), Co-Diagnostics (CODX), Aduro Biotech (ADRO), iBio (IBIO), Aethlon Medical (AEMD), (ALT), Amarin (AMRN), Actinium Pharmaceuticals (ATNM) and Biocept (BIOC).

What is Blonder Tongue Laboratories' stock symbol?

Blonder Tongue Laboratories trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "BDR."

How do I buy shares of Blonder Tongue Laboratories?

Shares of BDR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Blonder Tongue Laboratories' stock price today?

One share of BDR stock can currently be purchased for approximately $1.04.

How much money does Blonder Tongue Laboratories make?

Blonder Tongue Laboratories has a market capitalization of $12.89 million and generates $16.38 million in revenue each year. The technology company earns $-7.47 million in net income (profit) each year or ($0.18) on an earnings per share basis.

How many employees does Blonder Tongue Laboratories have?

Blonder Tongue Laboratories employs 85 workers across the globe.

What is Blonder Tongue Laboratories' official website?

The official website for Blonder Tongue Laboratories is www.blondertongue.com.

Where are Blonder Tongue Laboratories' headquarters?

Blonder Tongue Laboratories is headquartered at 1 Jake Brown Rd PO Box 1000, OLD BRIDGE, NJ 08857-1000, United States.

How can I contact Blonder Tongue Laboratories?

Blonder Tongue Laboratories' mailing address is 1 Jake Brown Rd PO Box 1000, OLD BRIDGE, NJ 08857-1000, United States. The technology company can be reached via phone at (732) 679-4000, via email at [email protected], or via fax at 732-679-4353.

This page was last updated on 11/27/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.